Elevai Labs subsidiary announces results from E-series exosome technology

Elevai Labs announced positive case study results from patients undergoing laser therapy followed by use of Elevai E-Series for applications in melasma. Elevai believes that these case studies can be the premise for future exosome research on effective melasma solutions. The case study assessments came from four female Vietnamese patients, aged 35 to 40 years old, diagnosed with moderate to severe mixed type melasma. Melasma lesions were concentrated and localized on both cheeks in all four patients. A triple combination method was applied. The four case studies on individuals with melasma experienced significant improvement after two months of using Elevai topical exosome products following laser treatment. After six months of follow-up, there was no melasma recurrence.